Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Gifford, Robert J.; Liu, Tommy F.; Rhee, Soo-Yon; Kiuchi, Mark; Hue, Stephane; Pillay, Deenan; Shafer, Robert W. (2009)
Publisher: Oxford University Press
Journal: Bioinformatics
Languages: English
Types: Article
Subjects: Sequence Analysis, Applications Note

Classified by OpenAIRE into

mesheuropmc: education, health care economics and organizations, health services administration, natural sciences
ACM Ref: ComputingMethodologies_PATTERNRECOGNITION, GeneralLiterature_MISCELLANEOUS
Summary: The calibrated population resistance (CPR) tool is a web-accessible program for performing standardized genotypic estimation of transmitted HIV-1 drug resistance. The program is linked to the Stanford HIV drug resistance database and can additionally perform viral genotyping and algorithmic estimation of resistance to specific antiretroviral drugs. Availability: http://cpr.stanford.edu/cpr/index.html Contact:
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • Bennett,D.E. et al. (2008a) The World Health Organization's global strategy for prevention and assessment of HIV drug resistance. Antivir. Ther., 13(Suppl. 2), 1-13.
    • Bennett,D.E. et al. (2008b) Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment. Antivir. Ther., 13 (Suppl. 2), 25-36.
    • Bertagnolio,S. et al. (2007) HIV-1 drug resistance surveillance using dried whole blood spots. Antivir. Ther., 12, 107-113.
    • Gifford,R.J. et al. (2008) Sequence editing by Apolipoprotein B RNA-editing catalytic component and epidemiological surveillance of transmitted HIV-1 drug resistance. AIDS, 22, 717-725.
    • Gilks,C.F. et al. (2006) The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet, 368, 505-510.
    • Holmes,R.K. et al. (2007) APOBEC-mediated viral restriction: not simply editing? Trends Biochem. Sci., 32, 118-128.
    • Huang,X. and Zhang,J. (1996) Methods for comparing a DNA sequence with a protein sequence. Comput. Appl. Biosci., 12, 497-506.
    • Kuritzkes,D.R. et al. (2008) Preexisting resistance to nonnucleoside reversetranscriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects. J. Infect. Dis., 197, 867-870.
    • Little,S.J. et al. (2002) Antiretroviral-drug resistance among patients recently infected with HIV. N. Engl. J. Med., 347, 385-394.
    • Liu,T.F. and Shafer,R.W. (2006) Web resources for HIV type 1 genotypic-resistance test interpretation. Clin. Infect. Dis., 42, 1608-1618.
    • Myers, et al. (2005) A statistical model for HIV-1 sequence classification using the subtype analyser (STAR). Bioinformatics, 21, 3535-3540.
    • Pillay,D. (2004) Current patterns in the epidemiology of primary HIV drug resistance in North America and Europe. Antivir. Ther., 9, 695-702.
    • Rhee,S.Y. et al. (2003) Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucleic Acids Res., 31, 298-303.
    • Shafer,R.W. et al. (2007) HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance. AIDS, 21, 215-223.
    • Shafer,R.W. et al. (2008) Consensus drug resistance mutations for epidemiological surveillance: basic principles and potential controversies. Antivir. Ther., 13(Suppl. 2), 59-68.
    • SPREAD Programme (2008) Transmission of drug-resistant HIV-1 in Europe remains limited to single classes. AIDS, 22, 625-635.
    • UK Collaborative Group on HIV Drug Resistance (2007) Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom. AIDS, 21, 1035-1039.
    • van de Vijver,D.A.M.C et al. (2007) The epidemiology of transmission of drug resistant HIV-1. In Leitner,T. et al. (eds) HIV Sequence Compendium 2007. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM.
    • Yerly,S. et al. (2007) Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey. AIDS, 21, 2223-2229.
  • No related research data.
  • No similar publications.

Share - Bookmark

Funded by projects

Cite this article